Enzoheal Tablet is a combination pharmaceutical formulation containing Bromelain 90 mg, Trypsin 48 mg, and Rutoside 100 mg, designed to provide anti-inflammatory, fibrinolytic, and antioxidant effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins and reduces inflammation and edema in various inflammatory conditions. Trypsin, a serine protease enzyme, enhances the degradation of fibrin and other necrotic tissues, promoting wound healing and tissue repair. Rutoside, a bioflavonoid, exhibits potent antioxidant properties and strengthens capillary walls, thereby reducing capillary fragility and improving microcirculation. The synergistic action of these active ingredients makes Enzoheal Tablet effective in managing post-traumatic edema, inflammatory disorders, and vascular conditions associated with increased capillary permeability. It is commonly prescribed as an adjunct therapy in soft tissue injuries, surgical recovery, and chronic venous insufficiency. Enzoheal Tablet should be administered under medical supervision, with dosage tailored to the patient’s clinical condition. Caution is advised in patients with hypersensitivity to any component or those with bleeding disorders. Adverse effects are generally mild and infrequent but may include gastrointestinal discomfort or allergic reactions. This formulation supports accelerated recovery by modulating inflammation, enhancing enzymatic debridement, and improving vascular integrity.